Skip to content

Author

R. Medarametla

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Fenofibrate Colon-Targeted Nanosponges Development, Optimization, and In-Vivo Anti-Inflammatory Efficacy of Fenofibrate Nanosponges: A Box–Behnken Design Approach to Formulation, Pharmacokinetics, and Experimental Colitis

Background: Fenofibrate, a PPAR-α agonist with anti-inflammatory, lipid-modulating and lipid-lowering properties, is limited clinically by poor aqueous solubility and low oral bioavailability, restricting its use for inflammatory bowel disease (IBD). This study aimed to develop and optimize fenofibrate nanosponge formu...

R. Medarametla · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.